Lauren Mifflin
InvestorPrincipal of Company Creation at Frazier Life Sciences · Board director at Aldebaran Therapeutics
Boston
About
Lauren Mifflin joined Frazier Life Sciences in 2023 as a Principal of Company Creation and is CEO/Co-Founder of Counterakt Therapeutics. She previously served as COO of Hillstar Bio, was a venture partner at 82VS (the venture studio of Alloy Therapeutics), and held fellow and operating associate roles at 5AM Ventures, where she worked with the founding teams of Entrada Therapeutics and Nido Biosciences. Earlier she was a health tech investor at Jump Capital and a consultant at Monitor Group/Monitor Deloitte, and she holds a Ph.D. and M.M.Sc. from Harvard, an M.B.A. from the University of Chicago, and undergraduate degrees from the University of Pennsylvania/Wharton.
Invests in
Biotech
Board director at Aldebaran Therapeutics
Intro paths
→
In turn, Lauren can intro founders to Aldebaran Therapeutics's investors below.
Aldebaran Therapeutics's investors · 1
Experience
- StealthCoCo-Founder, Board Directorcurrent2025 — present
- Counterakt TherapeuticsCo-Founder, CEO, Board Directorcurrent2024 — present
- Frazier Life SciencesPrincipal, Company Creationcurrent2025 — present
- Frazier Life SciencesVice President, Company Creation2023 — 2025
- Hillstar BioCOOcurrent2024 — present
- Ypsilon TherapeuticsCo-Founder, Founding CBO, Board Director2022 — 2023
- Synkentro TherapeuticsCo-Founder, Board Director2022 — 2023
- 82VSVenture Partner2021 — 2023
- Nido BiosciencesSenior Scientist, ALS Biology Lead2018 — 2021
- 5AM Ventures4:59 Operating Associate2018 — 2020
- 5AM VenturesFellow2017 — 2018
- Entrada TherapeuticsFellow/Consultant2017 — 2019
- Jump CapitalAssociate2014 — 2016Chicago, IL
- Monitor Deloitte & Monitor GroupConsultant2011 — 2014New York City, NY
- Insight Strategy AdvisorsAnalyst2010New York City, NY
- sanofi-aventisPre-Clinical Neuroscience Discovery Research Intern2009Paris Area, France
Skills & more
- Preparing to be a Corporate Director — Harvard Business School Executive Education
- NACD Accelerate — NACD (National Association of Corporate Directors)
From Lauren's professional profile.
Deals · 1
Aldebaran TherapeuticsBoard seat
via Frazier Life Sciences · filed Mar 2022 · $1.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Sudo Bio
Investor
Counterakt Therapeutics
Sources: SEC Form D filings · the firm's website.
Colleagues at Frazier Life Sciences
Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences
Anna H. Chen
Partner at Frazier Life Sciences
Frequently asked questions
- Who is Lauren Mifflin?
- Lauren Mifflin joined Frazier Life Sciences in 2023 as a Principal of Company Creation and is CEO/Co-Founder of Counterakt Therapeutics. She previously served as COO of Hillstar Bio, was a venture partner at 82VS (the venture studio of Alloy Therapeutics), and held fellow and operating associate roles at 5AM Ventures, where she worked with the founding teams of Entrada Therapeutics and Nido Biosciences. Earlier she was a health tech investor at Jump Capital and a consultant at Monitor Group/Monitor Deloitte, and she holds a Ph.D. and M.M.Sc. from Harvard, an M.B.A. from the University of Chicago, and undergraduate degrees from the University of Pennsylvania/Wharton.
- Where does Lauren Mifflin work?
- Lauren Mifflin is Principal of Company Creation at Frazier Life Sciences and Board director at Aldebaran Therapeutics.
- What does Lauren Mifflin invest in?
- Lauren Mifflin invests in Biotech.
- What boards does Lauren Mifflin sit on?
- Lauren Mifflin holds tracked board seats at Aldebaran Therapeutics, Sudo Bio.
- What companies has Lauren Mifflin invested in?
- Investments tracked here include Counterakt Therapeutics.
- Where did Lauren Mifflin go to school?
- Lauren Mifflin studied at Harvard University (Doctor of Philosophy - PhD, Biological and Biomedical Sciences); Harvard Medical School (Master of Medical Sciences (MMSc), Immunology); The University of Chicago Booth School of Business (Master of Business Administration (MBA), Entrepreneurship & Finance).
Same school
Also attended Harvard University1,999
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGBill GatesCo-founder of Microsoft; Chair of the Gates Foundation
+ 1,993 more
Also attended Harvard Medical School181
Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 175 more
Also attended The Wharton School2,000
Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis Ventures
+ 1,994 more
Also attended University of Pennsylvania1,082
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 1,076 more
Shared employers
Also worked at StealthCo2
Also worked at Ypsilon Therapeutics2
Also worked at 5AM Ventures35
Anika GuptaInvestor at GV (Google Ventures)Susan LiuInvestment Team at 8VCGisella de la RochaVice President of Legal at MPM BioImpactMira ChaurushiyaManaging Director at Westlake Village BioPartnersLucy LiuPrincipal at Longwood FundKush M ParmarManaging Partner at 5AM Ventures
.jpg)
+ 29 more
Also worked at Monitor Deloitte & Monitor Group107
Erica WuInvestment Director at Intel CapitalCandice FaktorFounder, CEO, speaker, and investor focused on unlocking human potential in the age of AIParth DesaiPartner at Flare Capital PartnersThuy-Linh UongStrategy & Corp. Development Manager at Emerald Technology Ventures AgAaron SamuelsInvestor, Entrepreneur, Artist, StorytellerNiccolò ManzoniManaging Partner at Five Seasons Ventures
+ 101 more